Home > Insider Trading > Filing (0001209191-23-024851)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1861560	Nuvalent Inc.	NUVL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1868741	Ann Deborah Miller	C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2023-04-17	2,000	$6.89	2,000	No	4	M	Direct
Class A Common Stock	Disposition	2023-04-17	125	$29.33	1,875	No	4	S	Direct
Class A Common Stock	Disposition	2023-04-17	1,875	$30.15	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2023-04-17	2,000	$0.00	2,000	$6.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
213,170		2031-04-29	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.67 to $29.60, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $30.58, inclusive.
The shares underlying this option vest as follows: 25% of the shares vested on April 15, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.